Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer

Vorvis, C., Hatziapostolou, M. ORCID: 0000-0003-2493-7028, Mahurkar-Joshi, S., Koutsioumpa, M., Williams, J., Donahue, T.R., Poultsides, G.A., Eibl, G. and Iliopoulos, D., 2016. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. American Journal of Physiology - Gastrointestinal and Liver Physiology, 310 (11), G1124-G1137. ISSN 0193-1857

[img]
Preview
Text
33816_a1041_Hatziapostolou.pdf - Post-print

Download (1MB) | Preview

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with low survival rates and limited therapeutic options. Thus elucidation of signaling pathways involved in PDAC pathogenesis is essential for identifying novel potential therapeutic gene targets. Here, we used a systems approach to elucidate those pathways by integrating gene and microRNA profiling analyses together with CRISPR/Cas9 technology to identify novel transcription factors involved in PDAC pathogenesis. FOXA2 transcription factor was found to be significantly downregulated in PDAC relative to control pancreatic tissues. Functional experiments revealed that FOXA2 has a tumor suppressor function through inhibition of pancreatic cancer cell growth, migration, invasion, and colony formation. In situ hybridization analysis revealed miR-199a to be significantly upregulated in pancreatic cancer. Bioinformatics and luciferase analyses showed that miR-199a negatively but directly regulates FOXA2 expression through binding in its 3′-untranslated region (UTR). Evaluation of the functional importance of miR-199a on pancreatic cancer revealed that miR-199a acts as an inhibitor of FOXA2 expression, inducing an increase in pancreatic cancer cell proliferation, migration, and invasion. Additionally, gene ontology and network analyses in PANC-1 cells treated with a small interfering RNA (siRNA) against FOXA2 revealed an enrichment for cell invasion mechanisms through PLAUR and ERK activation. FOXA2 deletion (FOXA2Δ) by using two CRISPR/Cas9 vectors in PANC-1 cells induced tumor growth in vivo resulting in upregulation of PLAUR and ERK pathways in FOXA2Δ xenograft tumors. We have identified FOXA2 as a novel tumor suppressor in pancreatic cancer and it is regulated directly by miR-199a, thereby enhancing our understanding of how microRNAs interplay with the transcription factors to affect pancreatic oncogenesis.

Item Type: Journal article
Publication Title: American Journal of Physiology - Gastrointestinal and Liver Physiology
Creators: Vorvis, C., Hatziapostolou, M., Mahurkar-Joshi, S., Koutsioumpa, M., Williams, J., Donahue, T.R., Poultsides, G.A., Eibl, G. and Iliopoulos, D.
Publisher: American Physiological Society
Date: 1 June 2016
Volume: 310
Number: 11
ISSN: 0193-1857
Identifiers:
NumberType
10.1152/ajpgi.00035.2016DOI
671827Other
Divisions: Schools > School of Science and Technology
Record created by: Linda Sullivan
Date Added: 05 Jun 2018 08:53
Last Modified: 31 May 2021 15:14
URI: http://irep.ntu.ac.uk/id/eprint/33816

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year